Overview
Offer Zeira practices practicing medicine in Lodi, Italy.
Their clinical expertise encompasses Hallervorden-Spatz Disease, Paraplegia, Osteosarcoma, and Mesothelioma.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Offer Zeira
Is Offer Zeira a top-rated expert for Hallervorden-Spatz Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Offer Zeira is classified as an Experienced expert for Hallervorden-Spatz Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Offer Zeira participate in research or clinical trials?
Yes. Offer Zeira has published 15 articles and abstracts on conditions like Hallervorden-Spatz Disease. You can view a list of Offer Zeira's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hallervorden-Spatz DiseaseZeira isExperienced. Learn about Hallervorden-Spatz Disease.
- MesotheliomaZeira isExperienced. Learn about Mesothelioma.
- OsteosarcomaZeira isExperienced. Learn about Osteosarcoma.
- ParaplegiaZeira isExperienced. Learn about Paraplegia.